Related Experiment Video
Updated: May 3, 2026
06:19
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.9K
Targeting ion transport in cancer
1Department of Urology, 267 Experimental Urology, Radboud University Medical Center, , PO Box 9101, Nijmegen 6500 HB, The Netherlands.
Summary
Cancer cells exhibit altered metabolism and ion transport, making them vulnerable. Targeting carbonic anhydrase IX (CAIX) exploits the acidic tumor microenvironment for novel cancer therapies.
Area of Science:
- Oncology
- Cancer Metabolism
- Biochemistry
Background:
- Cancer cell metabolism significantly deviates from normal cells, impacting ion transport.
- Tumor acidity, a hallmark of the tumor microenvironment, is an emerging therapeutic target.
- Carbonic anhydrase IX (CAIX) plays a crucial role in regulating tumor pH.
Purpose of the Study:
- To explore the potential of targeting the acidic, hypoxic tumor environment for cancer therapy.
- To discuss the clinical relevance and application of targeting CAIX in cancer patients.
Main Methods:
- Review of existing literature on cancer metabolism and ion transport.
- Analysis of CAIX expression patterns in cancer versus normal tissues.
- Discussion of therapeutic strategies targeting CAIX.
Main Results:
- CAIX is highly expressed in many cancers but minimally in normal tissues, making it a selective target.
- The acidic tumor microenvironment, regulated by CAIX, presents a unique vulnerability.
- Clinical experience with CAIX-targeting agents is being evaluated.
Conclusions:
- Exploiting the acidic tumor microenvironment via CAIX inhibition is a promising therapeutic strategy.
- CAIX targeting offers a selective approach with potential for reduced side effects.
- Further clinical investigation of CAIX-targeted therapies is warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:57Targeted Cancer Therapies
1.4K
1.4K
01:46Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
01:26Targets for Drug Action: Overview
9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K